CXCL8 and autoimmune polyendocrinopathy: The same U0126 treatment also reduced CXCL8-3’ reporter protein levels in HL-60 Mac; but did not reduce the expression of the APS-deficient reporters: CXCL8-5’, TNF-5’+3’ and IL6-5’+3’ (Fig 6A).